Godavari Drugs Ltd — Important, 15-01-2026: Company Update

Godavari Drugs has approved a preferential issue of up to 23.60 lakh convertible warrants at Rs. 89 each to promoters, worth approximately Rs. 20.99 crore. The board also approved issuing up to 25.97 lakh equity shares at Rs. 89 each to promoters and non-promoters, totaling around Rs. 23.11 crore. These fundraising efforts will alter the shareholding structure, with promoters holding 51.52% post-allotment and warrant conversion. Shareholder approval is required at an upcoming Extra Ordinary General Meeting.